Related Experiment Video
Updated: Apr 16, 2026

From a Natural Product to Its Biosynthetic Gene Cluster: A Demonstration Using Polyketomycin from Streptomyces diastatochromogenes Tü6028
Published on: January 13, 2017
Concentrated biosynthesis of tobramycin by genetically engineered Streptomyces tenebrarius
Jianping Xiao1, Hui Li, Shuping Wen
1College of Biological Science and Technology, Fuzhou University.
Abstract:
Tobramycin is an important broad spectrum aminoglycoside antibiotic widely used against severe Gram-negative bacterial infections. It is produced by base-catalyzed hydrolysis of carbamoyltobramycin (CTB) generated by S. tenebrarius. We herein report the construction of a genetically engineered S. tenebrarius for direct fermentative production of tobramycin by disruption of aprK and tobZ. A unique putative NDP-octodiose synthase gene aprK was disrupted to optimize the production of CTB, resulting in the blocking of apramycin biosynthesis and the obvious increase in CTB production of aprK disruption mutant S. tenebrarius ST316. Additional mutation on the carbamoyltransferase gene tobZ in S. tenebrarius ST316 generated a strain ST318 that produces tobramycin as a single metabolite. ST318 could be used for industrial fermentative production of tobramycin.
More Related Videos
Related Concept Videos
Production of Antibiotics
Production of Pharmaceuticals
Production of Biopesticides
Bioreactor Controls-III
Biosynthesis in Bacteria
Upstream Processing

